Muhammad Latif

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Intellectual Disability

Advanced Non Small Cell Lung Cancer

Cerebrospinal Fluid

Drug Administration

Top Venues

Drug development research

The journal of gene medicine

Molecules (Basel, Switzerland)

Taibah University

Korea University of Science and Technology (UST) (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Taibah University Oct 10o 2015

Saudi Arabia

Assistant Professor/Head of Biochemical Lab :: Biochemical Lab, Centre for Genetics and Inherited Disease

Education History

Korea University of Science and Technology (UST) Feb 23o 2011 - Aug 14o 2014

South Korea

PHD :: Korea Research Institute of Science and Technology

Publications

Muhammad Asam Raza, Muhammad Waseem Mumtaz, Seyhan Ozturk, Muhammad Latif, null Aisha, Adnan Ashraf, Necmi Dege, Onur Erman Dogan, Erbil Agar, Shafiq Ur Rehman, Awal Noor
Experimental and Theoretical Biological Probing of Schiff Bases as Esterase Inhibitors: Structural, Spectral and Molecular Insights. Molecules (Basel, Switzerland) 28 (15) (2023)
Muhammad Ismail Khan, Muhammad Latif, Maria Saif, Hilal Ahmad, Atta Ullah Khan, Muhammad Imran Naseer, Hafiz Muhammad Jafar Hussain, Musharraf Jelani
Whole exome sequencing identified a novel missense alteration in CC2D2A causing Joubert syndrome 9 in a Pakhtun family. The journal of gene medicine 23 (1) (2020)
Zafar Iqbal, Ambreen Iqbal, Zaman Ashraf, Muhammad Latif, Mubashir Hassan, Humaira Nadeem
Synthesis and docking studies of N-(5-(alkylthio)-1,3,4-oxadiazol-2-yl)methyl)benzamide analogues as potential alkaline phosphatase inhibitors. Drug development research 80 (5) (2019)
Muhammad Latif, Zaman Ashraf, Sulman Basit, Abdul Ghaffar, Muhammad Sohail Zafar, Aamer Saeed, Sultan Ayoub Meo
Latest perspectives of orally bioavailable 2,4-diarylaminopyrimidine analogues (DAAPalogues) as anaplastic lymphoma kinase inhibitors: discovery and clinical developments. RSC advances 8 (30) (2018)